Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover More
Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover InnovationsNavigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTech
Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsUnlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock Innovations
Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansLeverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline Decisions
Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover More
Transform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.
Explore NowA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS
Enhance your evidence generation, accelerate speed to market, cut research costs, conduct studies more efficiently, and secure payer approvals with Real World Solutions powered by IQVIA Connected Intelligence. It’s time to embrace real world data (RWD) and real world evidence (RWE) to create intelligent connections across data, stakeholders, technologies, and services to discover previously unseen insights, drive smarter decision-making, and unleash new opportunities.
Tap into tailored solutions to solve your most complex challenges with IQVIA Connected Intelligence.
By leveraging deep domain expertise combined with scientific rigor and unparalleled data, IQVIA works with you to harness the right real world evidence at the right time, throughout your product’s lifecycle.
Whether you need real world evidence for epidemiology and drug safety, health economics outcomes research (HEOR), medical affairs, evidence generation, or uncovering insights into the natural history of disease or patient burden of illness, IQVIA works as an extension of your organization to meet your goals, and helps you meet regulatory, payer, provider, and patient needs with confidence.
The Regulatory Science Series provides a platform to share applied learnings, advance innovations, and improve public health. Through IQVIA’s public comments submitted to regulatory bodies, we integrate clinical, technical, and real world evidence insights. Our goal is to inform regulatory science and policy by discussing topics such as real world data, clinical trial design, digital health technologies, drug safety, and post-market surveillance.
